Results

Total Results: 2,208 records

Showing results for "drug".

  1. effectivehealthcare-admin.ahrq.gov/products/c-difficile-update/research-protocol
    December 01, 2019 - Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based … drug therapy.fs. randomly.ab. trial.ab. groups.ab.
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
    December 23, 2014 - Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based … randomized controlled trial.pt. 5 controlled clinical trial.pt. 6 randomized.ab. 7 placebo.ab. 8 drug
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
    April 08, 2024 - as similar to human milk as possible and is established and strictly regulated by the Federal Food, Drug … J Food Drug Anal. 2021 Mar 15;29(1):1-14. doi: 10.38212/2224- 6614.3107. PMID: 35696228. 8.
  4. effectivehealthcare-admin.ahrq.gov/news/2020-year-in-review
    March 01, 2021 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
    May 22, 2023 - participants for dietary/lifestyle interventions while requiring biopsies, as supposed to industry drug
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Tympanostomy Tubes Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Tympanostomy Tubes I. Background Info…
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/telehealth-covid-19-disposition-comments.pdf
    January 03, 2023 - We do so by funding research and drug development, advancing high-quality, specialized care, and partnering
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/case-management_research-protocol.pdf
    June 06, 2011 - means to prevent adverse clinical events, such as falls, preventable hospitalizations, or adverse drug
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - Research White Paper Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence Research White Paper Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence Prepared for: Agency for Healthc…
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
    January 01, 2023 - N Mean Age (SD) Baseline CY-BOCS Score, Mean (SD) Intervention Type Pharmacolgical Interventions, Drug … Class (e.g., SSRI) Pharmacolgical Interventions, Drug Name Behavioral Intervention, Components (Choose
  11. effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
    December 01, 2019 - percutaneous coronary intervention Dabigatran (Pradaxa®) Boehringer Ingelheim GmbH Investigational drug … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil-Janssen Investigational drug, not yet
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - percutaneous coronary intervention Dabigatran (Pradaxa®) Boehringer Ingelheim GmbH Investigational drug … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil- Janssen Investigational drug, not
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
    February 01, 2008 - percutaneous coronary intervention Dabigatran (Pradaxa®) Boehringer Ingelheim GmbH Investigational drug … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil- Janssen Investigational drug, not
  14. effectivehealthcare-admin.ahrq.gov/products/cervical-degenerative-disease/protocol
    July 01, 2022 - filter) RCT hedge (sensitive) ((((((((groups[tiab])) OR (trial[tiab])) OR (randomly[tiab])) OR (drug
  15. effectivehealthcare-admin.ahrq.gov/products/worker-safety-wellness/protocol
    December 01, 2024 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ocd-protocol.pdf
    August 15, 2023 - magnetic resonance imaging NRCS Nonrandomized comparative study NSAID Nonsteroidal anti-inflammatory drug
  17. effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014
    August 01, 2019 - generated from the IT system, of what behavior is needed at a particular point in time, as well as (for drug
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
    December 01, 2024 - Medicaid Services (CMS) to cover multicancer detection tests approved by the United States Food and Drug … Food and Drug Administration. Laboratory Developed Tests. 2024. … Department of Health and Human Services Food and Drug Administration. … Food and Drug Administration. … deoxyribonucleic acid EHC Effective Health Care EPC Evidence-based Practice Center FDA Food and Drug
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research-2013.pdf
    January 01, 2013 - inflammatory arthritis, arthritis secondary to systemic disease, and physical therapy treatment combined with drug … The former refers to a drug or device being tested, while the latter is the data on patients randomized … to a particular drug or device in a single study.
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - As the intervention is non-drug randomization may not offer as large a barrier as in a drug trial. … In some diseases there is evidence that periods of drug free remission can be achieved. … Effective Health Care Program Selection Criteria Appropriateness • Represents a health care drug,

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: